BSE filing, NSE: GUFICBIO. Summary written from the filing by ALFA Finder's alert engine.
Gufic BioSciences Ltd: key numbers
- Share price
- ₹431.00
- Market cap
- ₹4,322 Cr
- Revenue (annual)
- ₹944.0 Cr
- Net profit (annual)
- ₹64.21 Cr
- P/E (TTM)
- 58.8×Sector 42.0×
- Promoter holding
- 72.50%+0.00% QoQ
- FII holding
- 0.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gufic BioSciences Ltd
All →Gufic BioSciences Legal & Regulatory
Gufic Biosciences' tax dispute moved after the ITAT remanded matters to the Assessing Officer. The residual Rs. 11.76 lakh demand will be redetermined in fresh assessment.
- Value
- ₹0.12 Cr
Gufic BioSciences Legal & Regulatory
Gufic Biosciences disclosed an ITAT Mumbai order for AY 2023-24 that set aside the CIT(A) findings and restored the matter to the Assessing Officer. No demand arises from the order, and the tax liability will be determined after fresh assessment.
Gufic BioSciences Business Update
Gufic Biosciences reported a USFDA pre-approval inspection at its Indore facility, concluding October 23, 2026. The inspection produced three Form 483 observations, now being addressed.
Gufic BioSciences Other Announcement
Gufic Biosciences Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Gufic BioSciences Legal & Regulatory
Gufic Biosciences received a favorable appellate order from the Income Tax Commissioner. This order deletes an income tax demand of Rs. 4.33 Crore.
- Value
- ₹4.33 Cr
Gufic BioSciences Other Announcement
Gufic Biosciences Limited received an overall ESG rating of 62 (Category: Strong) from Crisil for FY 2025-26, assigned independently by the rating agency.
Other board meeting date announcements
All →Swelect Energy Systems Board Meeting Date
Swelect Energy Systems will hold a board meeting on November 13, 2026. Agenda includes Q2 and H1 FY27 unaudited results and an Employee Stock Option Scheme.
HDB Financial Services Board Meeting Date
HDB Financial Services schedules a 13 November 2026 committee meeting to consider fund raising. The agenda is a debt issue, with no amount stated.
Panchatv Bharat Board Meeting Date
Panchatv Bharat schedules a 13 November 2026 board meeting to approve half-year unaudited results. The trading window stays closed until 48 hours after the results.
Dolat Algotech Board Meeting Date
Dolat Algotech Ltd has intimated a board meeting on 14 November 2026 to consider unaudited standalone and consolidated results for the quarter and six months ended 30 September 2026. The trading window for designated persons is also closed until 48 hours after results.
Sangani Hospitals Board Meeting Date
Sangani Hospitals will hold a board meeting on November 14, 2026 to consider unaudited half-year results. The trading window remains closed until November 16, 2026.
Edelweiss Financial Services Board Meeting Date
Edelweiss Financial Services has scheduled a board meeting for November 13, 2026 to consider unaudited quarterly and half-year results. This prior intimation discloses no financial figures.